Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRA | AMGN | VRTX | REGN | GILD |
| Company | Atara Biotherap | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 8.34 | 310.25 | 469.76 | 1,054.00 | 68.30 |
| High | 8.34 | 312.43 | 477.93 | 1,058.17 | 68.49 |
| Low | 7.31 | 307.64 | 467.41 | 1,030.23 | 67.58 |
| Last | 7.52 | 310.77 | 473.78 | 1,044.66 | 68.40 |
| Change | -0.84 | -0.24 | +2.53 | -12.36 | -0.24 |
| % Change | -10.05% | -0.08% | +0.54% | -1.17% | -0.35% |
| Volume | 93,600 | 1,542,800 | 852,500 | 364,200 | 4,846,100 |
| 20-Day Average Volume | 132,971 | 2,432,280 | 1,282,940 | 476,210 | 9,328,090 |
| Previous Close | 8.36 | 311.01 | 471.25 | 1,057.02 | 68.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.82 | 307.73 | 475.85 | 1,034.79 | 66.52 |
| 20-Day Raw Stochastic | 5.40% | 50.19% | 45.48% | 61.38% | 60.19% |
| 20-Day Relative Strength | 30.18% | 55.86% | 60.54% | 61.18% | 54.59% |
| Weighted Alpha | -77.37 | +36.35 | +41.72 | +47.36 | -10.41 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.34% since 06/25/24 | -2.67% since 06/25/24 | -0.01% since 06/25/24 | -2.48% since 06/25/24 | -1.74% since 06/25/24 |
| Low | 7.07 on 06/27/24 | 307.64 on 07/02/24 | 467.41 on 07/02/24 | 1,030.23 on 07/02/24 | 67.58 on 07/02/24 |
| High | 9.10 on 06/28/24 | 319.00 on 07/01/24 | 481.14 on 06/26/24 | 1,075.30 on 06/26/24 | 70.23 on 06/26/24 |
| 1-Month | |||||
| %Chg | -46.37% since 05/31/24 | +1.61% since 05/31/24 | +4.05% since 05/31/24 | +6.58% since 05/31/24 | +6.43% since 05/31/24 |
| Low | 7.07 on 06/27/24 | 295.30 on 06/13/24 | 453.73 on 06/03/24 | 979.26 on 06/03/24 | 62.69 on 06/18/24 |
| High | 15.41 on 06/04/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -58.66% since 04/02/24 | +12.51% since 04/02/24 | +15.72% since 04/02/24 | +9.43% since 04/02/24 | -5.12% since 04/02/24 |
| Low | 7.07 on 06/27/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 20.81 on 04/04/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -37.32% since 01/02/24 | +4.50% since 01/02/24 | +15.30% since 01/02/24 | +15.43% since 01/02/24 | -17.83% since 01/02/24 |
| Low | 7.07 on 06/27/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 39.50 on 02/02/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,267 | 166,836,656 | 121,607,480 | 116,468,800 | 85,515,352 |
| Shares Outstanding, K | 4,817 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 8,570,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -276,130,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 27,360,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -31,750,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.52 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -5.75 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/13/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.77 | 31.12 | 28.32 | 17.02 |